Swisher SG , Erasmus J, Maish M, Correa AM, Macapinlac H, Ajani JA, Cox JD, Komaki RR, Hong D, Lee HK, Putnam JB Jr, Rice DC, Smythe WR, Thai L, Vaporciyan AA, Walsh GL, Wu TT, Roth JA
Retatrutide is the lead triple agonist, hitting GLP-1, GIP, and glucagon receptors at once
Insulin-like Growth factor-1 (IGF-1) is a prohibited substance on the World Anti-Doping Agency (WADA) Prohibited List
377 Chronotype appears to have genetic and epigenetic underpinnings and varies with age and between genders
Mitchell JL, Lyons HS, Walker JK, Yiangou A, Grech O, Alimajstorovic Z, Greig NH, Li Y, Tsermoulas G, Brock K, Mollan SP, Sinclair AJ (2023) The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial
Biochim Biophys Acta 2008